CDCA8 was highly expressed in various malignant tumors, including adrenocortical carcinoma (ACC), cholangiocarcinoma (CHOL), renal clear cell carcinoma (KIRC), and so on (p < 0.05) (Figure 2A). This evidence concerns the gene CDCA8 and cholangiocarcinoma.